Adicet Bio, Inc. Share Price Today: Live Updates & Key Insights

Adicet Bio, Inc. share price today is $7.8408, up 0.63%. The stock opened at $8.19 against the previous close of $7.93, with an intraday high of $8.19 and low of $8.01.

Adicet Bio, Inc. Share Price Chart

Adicet Bio, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Adicet Bio, Inc. Share Price Performance

$7.8408 0.0063(0.63%) ACET at 10 Aug 2026 05:47 PM Biotechnology
Lowest Today 8.01
Highest Today 8.19
Today’s Open 8.19
Prev. Close 7.93
52 Week High 17.44
52 Week Low 6.01
Day’s Range: Low 8.01 High 8.19
52-Week Range: Low 6.01 High 17.44
1 day return -
1 Week return -13.41
1 month return -10.66
3 month return -1.23
6 month return +13.31
1 year return +1233.33
3 year return +280.04
5 year return +14.28
10 year return -

Adicet Bio, Inc. Institutional Holdings

RA Capital Management, LLC 12.65

Orbimed Advisors, LLC 11.00

Franklin Resources Inc 6.70

Franklin Biotechnology Discv A(acc)USD 4.29

Citadel Advisors Llc 4.08

Vanguard Capital Management, LLC 3.60

Woodline Partners LP 3.35

Adage Capital Partners Gp LLC 2.94

Prosight Management, LP 2.68

Vanguard Morn Total Stk Mkt Idx Investor 2.58

Renaissance Technologies Corp 2.49

Franklin Biotechnology Discovery A 2.41

Stonepine Capital Management Llc 2.37

Alyeska Investment Group, L.P. 2.18

The Carlyle Group Inc 1.97

NEXTBio Capital Management LP 1.69

Acadian Asset Management LLC 1.26

Geode Capital Management, LLC 1.08

Vanguard Institutional Extnd Mkt Idx Tr 1.06

Dafna Capital Management LLC 1.00

Burkehill Global Management, LP 0.67

Regeneron Pharmaceuticals Inc 0.65

ADAR1 Capital Management LLC 0.58

Vanguard Fiduciary Trust Co 0.54

Fidelity Extended Market Index 0.51

iShares Micro-Cap ETF 0.26

Fidelity Total Market Index 0.19

Dimensional US Small Cap ETF 0.16

Fidelity Series Total Market Index 0.13

Spartan Extended Market Index Pool F 0.13

DFA US Micro Cap I 0.12

Blackrock Extended Mkt Fund CF 0.12

Extended Equity Market Fund B 0.12

Extended Equity Market Fund E 0.12

NT Ext Equity Mkt Index Fund - Lending 0.11

BlackRock Extended Equity Market Fund K 0.10

NT Ext Equity Mkt Index Fund - NL 0.09

Vanguard Instl Ttl Stck Mkt Index Trust 0.08

Spartan Total Market Index Pool G 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Adicet Bio, Inc. Market Status

Strong Buy: 6

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Adicet Bio, Inc. Fundamentals

Market Cap 74.24 M

PB Ratio 0.6094

PE Ratio 0.0

Enterprise Value -38.34 M

Total Assets 192.36 M

Volume 80453

Adicet Bio, Inc. Company Financials

Annual Revenue FY23:0 0.0M, FY23:24990000 25.0M, FY22:9730000 9.7M, FY21:17903000 17.9M, FY20:995000 1.0M

Annual Profit FY23:-6098000 -6.1M, FY23:24990000 25.0M, FY22:9730000 9.7M, FY21:17903000 17.9M, FY20:995000 1.0M

Annual Net worth FY23:-142658000 -142.7M, FY23:-67029000 -67.0M, FY22:-61999000 -62.0M, FY21:-36678000 -36.7M, FY20:-28138000 -28.1M

Quarterly Revenue Q2/2026:null 0.0M, Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M

Quarterly Profit Q2/2026:null 0.0M, Q1/2026:-1342000 -1.3M, Q3/2025:-1600000 -1.6M, Q2/2025:-1600000 -1.6M, Q1/2025:-1680000 -1.7M

Quarterly Net worth Q2/2026:-21358000 -21.4M, Q1/2026:-20244000 -20.2M, Q3/2025:-26856000 -26.9M, Q2/2025:-31217000 -31.2M, Q1/2025:-28214000 -28.2M

About Adicet Bio, Inc. & investment objective

Company Information Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Organisation Biotechnology

Employees 102

Industry Biotechnology

CEO Mr. Chen Schor BA, CPA, M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Adicet Bio, Inc. FAQs

What is the share price of Adicet Bio, Inc. today?

The current share price of Adicet Bio, Inc. is $7.8408.

Can I buy Adicet Bio, Inc. shares in India?

Yes, Indian investors can buy Adicet Bio, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Adicet Bio, Inc. shares in India?

You can easily invest in Adicet Bio, Inc. shares from India by:

Can I buy fractional shares of Adicet Bio, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Adicet Bio, Inc.?

Adicet Bio, Inc. has a market cap of $74.24 M.

In which sector does Adicet Bio, Inc. belong?

Adicet Bio, Inc. operates in the Biotechnology sector.

What documents are required to invest in Adicet Bio, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Adicet Bio, Inc.?

The PE ratio of Adicet Bio, Inc. is N/A and the PB ratio is 0.61.